Journal of Stem Cell Research & Therapy

Annual Summit on Cell Signaling, Cell Therapy and Cancer Therapeutics

September 27-28, 2017 Chicago, USA

Scientific Tracks Abstracts

• Role of FOXA1 in prostate cancer and therapeutic resistance

  Jindan Yu

  PDF HTML

• Functional and mechanistic analysis of long non-coding RNAs in lung cancer

  Guoan Chen

  PDF HTML

• A novel role of BMI1 in prostate cancer

  Qi Cao

  PDF HTML

• FOXA1 defines cancer cell specificity

  Zhaoyu Li

  PDF HTML

• Targeting sulfiredoxin in colorectal cancer

  Qiou Wei

  PDF HTML

• The promise of epigenetic therapy in solid tumors: DNA methylation inhibitors in testicular cancer

  Michael J Spinella, Emmanuel Bikorimana, Ema Khan, Jennifer Rodrigues, Costantine Albany, Lawrence H Einhorn and Sarah J Freemantle

  PDF HTML

• G0S2 represses PI3K/AKT/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in estrogen receptor-positive breast cancer cells

  Sarah J Freemantle and Christina Y Yim, Emmanuel Bikorimana, Ema Khan, Jennifer Rodrigues, Michael J Spinella

  PDF HTML

• C/EBP-δ positively regulates MDSC expansion and endothelial VEGFR2 expression in tumor development

  P Charles Lin, Yongfen Min, Jingdong Li and Peng Qu

  PDF HTML

• Cell signaling and cancer therapy

  Sudha Bansode

  PDF HTML

• CD44-high alveolar type II cells show stem cell properties during steady-state alveolar homeostasis

  Yuru Liu

  PDF HTML

• Rationale for combinatorial approaches including PI3K-p110alpha targeting in brain cancer stem cells

  Frank Eckerdt

  PDF HTML

• Safety, efficacy and biology of the gp100 TCR-based bispecific T-cell redirector, IMCgp100 in advanced uveal melanoma

  Christina Coughlin

  PDF HTML

• Targeting Akt regulatory mechanisms for cancer therapy

  Pengda Liu

  PDF HTML

• Allosteric modulation of the Ras active site: from biochemistry to binding specificity

  Carla Mattos

  PDF HTML

• RhoC-Rock2 signaling regulate radio-resistance in cervical carcinoma by modulating DNA repair activity

  Sweta Srivastava, Annapurna P, Pavana Thomas, Avinash H Udayshankar, Sudhir Krishna, Jayashree Thatte and Cecil Ross

  PDF HTML

• Initiatives to advance stem cell science and medicine at Californiaâ??s $3 billion stem cell agency

  Stephen S Lin

  PDF HTML

• Novel nanotechnology approach to target cancer- switch from proto-oncogene to tumor suppressor

  Alexander Kazansky

  PDF HTML

• FOXP3-mediated Transcriptional Regulation of MicroRNAs in breast cancer

  Runhua Liu

  PDF HTML

• Modulation of Wnt signaling pathway, a strategy in urothelial carcinoma progression

  Ramiro Malgor

  PDF HTML

• miR-34c plays a key role in Theileria-transformed macrophages and human cancer cell lines by targeting PRKAR2B

  Malak Haidar, Hifzur Ansari, Zineb Rchiad, Fathia ben Rached, Arnab Pain and Gordon Langsley

  PDF HTML

• Stage-specific expression of CYP26B1 in the adult testis is responsible for pulsatile retinoic acid signaling in spermatogenesis

  Seyedmehdi Nourashrafeddin, Batool Hosseini Rashidi and Tony M Plant

  PDF HTML

• FGFR1 lentivirus lung cancer cell model for anti-cancer drug discovery and the study of FGFR1 signaling pathway

  Yiguang Lin, Eileen McGowan and Meng Xu

  PDF HTML

• Integrin inhibition in the tumor microenvironment

  Heloisa Sobreiro Selistre de Araujo

  PDF HTML

• High TSTA3 expression as a candidate biomarker of poor prognosis of ESCC patients

  Zianyi Wang

  PDF HTML

• MicroRNAs in oral cancers

  Kaiser Jamil

  PDF HTML

• Regulation of proteostasis in hMSCs: Proteasome activation enhances stemness and delays senescence

  Marianna Kapetanou

  PDF HTML

• Generation of a biologically and mechanically suitable 3D scaffold for heart valve

  Maryam Eslami, Ali Khademhosseini, Gholamreza Javadi, Nasser Agdami and Mohammad Ali Shokrgozar

  PDF HTML

• Trends and limitation in hydrogel-based therapies for myocardial regeneration

  Ali Mohammad Hasan Joshaghani, Maryam Eslami, Atefe Soluk, Karim Nayernia and Dariush Farhood

  PDF HTML